Free Trial

Novartis (NVS) News Today

Novartis logo
$160.59 +0.34 (+0.21%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$158.64 -1.95 (-1.21%)
As of 11/13/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novartis Latest News

Novartis Stock Gets Weaker EPS Estimate from Zacks Research
Novartis (NVS) Stock Forecast & Price Target
Novartis FY2026 Earnings Forecast Boosted by Zacks Research
Novartis Stock Gets Reduced EPS Estimate from Zacks Research
Novartis Stock Earnings Estimates Lifted by Zacks Research
Ethic Inc. Acquires 17,059 Shares of Novartis AG $NVS
Novartis AG $NVS Shares Sold by MGO One Seven LLC
Novartis at $165: What a Fresh 52-Week High Means Now
BioArctic collaborator Novartis terminates agreement
Novartis AG $NVS Stake Raised by Vise Technologies Inc.
Novartis AG (NVS) Q3 2026 Earnings Call Transcript
Novartis AG 2026 Q3 - Results - Earnings Call Presentation
What Novartis (NVS) Said on Its Q3 Earnings Call
Novartis (NVS) Q3 2026 Earnings Call Transcript

Novartis Media Mentions By Week

Novartis Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVS
News Sentiment
▼
0.55

0.57
▲
Average
Healthcare
News Sentiment

Novartis News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVS Articles
This Week
▼
22

10
▲
NVS Articles
Average Week

Novartis Trends on MarketBeat

This week vs. last week
New Followers
2
+100%
Searches
2
Page Views
2,349
-57%
Get Novartis News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Novartis dated 11/14/2026.
From Our Partners